Sheaff Brock Investment Advisors LLC bought a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 63,220 shares of the real estate investment trust's stock, valued at approximately $1,446,000.
Several other hedge funds have also made changes to their positions in DOC. HM Payson & Co. bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth approximately $25,000. S.A. Mason LLC bought a new stake in Healthpeak Properties during the 3rd quarter valued at $26,000. Rise Advisors LLC bought a new stake in Healthpeak Properties during the 3rd quarter valued at $29,000. Fortitude Family Office LLC bought a new stake in Healthpeak Properties during the 3rd quarter valued at $32,000. Finally, Barrett & Company Inc. bought a new stake in Healthpeak Properties during the 3rd quarter valued at $33,000. Institutional investors own 93.57% of the company's stock.
Shares of NYSE DOC opened at $20.86 on Friday. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93. The stock has a market capitalization of $14.59 billion, a price-to-earnings ratio of 44.38, a PEG ratio of 2.41 and a beta of 1.13. The stock's fifty day simple moving average is $22.29 and its 200 day simple moving average is $21.03. Healthpeak Properties, Inc. has a 52-week low of $16.01 and a 52-week high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.44 by ($0.32). Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The company had revenue of $700.40 million during the quarter, compared to analyst estimates of $682.51 million. During the same quarter in the previous year, the firm earned $0.45 earnings per share. The business's revenue was up 25.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.75%. Healthpeak Properties's dividend payout ratio is 255.32%.
DOC has been the topic of several recent analyst reports. Wells Fargo & Company reaffirmed an "equal weight" rating and set a $23.00 target price (up previously from $22.00) on shares of Healthpeak Properties in a research note on Tuesday, October 1st. Royal Bank of Canada lifted their target price on Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a "hold" rating to a "buy" rating and lifted their price target for the company from $20.00 to $28.00 in a research report on Monday, October 21st. Citigroup lifted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company a "neutral" rating in a research report on Thursday, August 22nd. Finally, Evercore ISI lifted their price target on Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a research report on Monday, September 16th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $22.86.
Check Out Our Latest Stock Analysis on DOC
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.